Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Boyko, E. J.
Right arrow Articles by Fujimoto, W. Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boyko, E. J.
Right arrow Articles by Fujimoto, W. Y.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes 45:1010-1015, 1996
© 1996 by the American Diabetes Association, Inc.


Low insulin secretion and high fasting insulin and C-peptide levels predict increased visceral adiposity. 5-year follow-up among initially nondiabetic Japanese-American men

ABSTRACT

Insulin resistance and hyperinsulinemia occur more frequently in subjects with greater visceral adiposity, but it is not known whether these metabolic abnormalities precede or follow visceral fat accumulation. We prospectively studied the development of visceral adiposity in relation to fasting and stimulated insulin and C-peptide levels. We followed 137 nondiabetic, second-generation Japanese-American men for changes in visceral adiposity over 5 years. Intra-abdominal fat (IAF) area (square centimeters) was measured at the umbilicus by computed tomography at baseline and after 5 years. Plasma insulin and C-peptide levels were measured after an overnight fast and during an oral glucose tolerance test. Beta-cell function was measured by the insulin secretion ratio (30-0 min plasma insulin difference)/(30-0 min plasma glucose difference). After adjustment for baseline IAF in multiple linear regression models, baseline fasting insulin (coefficient = 0.241, P = 0.048) and C-peptide (coefficient = 38.538, P < 0.001) levels were positively correlated, while the baseline insulin secretion ratio was negatively correlated with IAF change (coefficient = -0.099, P = 0.027). With IAF difference coded as a dichotomous variable (> 0 cm2 vs. < or = 0 cm2), the highest versus lowest tertile of baseline fasting insulin (odds ratio [OR] = 3.0, 95% CI 1.0-9.7) and fasting C-peptide (OR = 8.1, 95% CI 2.4-26.8) levels and the lowest versus highest tertile of the insulin secretion ratio (OR = 3.3, 95% CI 1.0-10.0) were associated with higher odds of IAF gain. Greater insulin resistance and reduced insulin secretion precede visceral fat accumulation in nondiabetic Japanese-American men.



Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
T. Hayashi, E. J. Boyko, M. J. McNeely, D. L. Leonetti, S. E. Kahn, and W. Y. Fujimoto
Visceral Adiposity, Not Abdominal Subcutaneous Fat Area, Is Associated With an Increase in Future Insulin Resistance in Japanese Americans
Diabetes, May 1, 2008; 57(5): 1269 - 1275.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
Z. T. Bloomgarden
Diabetes and Obesity: Part 1
Diabetes Care, December 1, 2007; 30(12): 3145 - 3151.
[Full Text] [PDF]


Home page
DiabetesHome page
J. Tong, W. Y. Fujimoto, S. E. Kahn, D. S. Weigle, M. J. McNeely, D. L. Leonetti, J. B. Shofer, and E. J. Boyko
Insulin, C-Peptide, and Leptin Concentrations Predict Increased Visceral Adiposity at 5- and 10-Year Follow-Ups in Nondiabetic Japanese Americans
Diabetes, April 1, 2005; 54(4): 985 - 990.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
M. Hallschmid, C. Benedict, B. Schultes, H.-L. Fehm, J. Born, and W. Kern
Intranasal Insulin Reduces Body Fat in Men but not in Women
Diabetes, November 1, 2004; 53(11): 3024 - 3029.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. H. Travers, B. W. Jeffers, and R. H. Eckel
Insulin Resistance during Puberty and Future Fat Accumulation
J. Clin. Endocrinol. Metab., August 1, 2002; 87(8): 3814 - 3818.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. J. Quon
Limitations of the Fasting Glucose to Insulin Ratio as an Index of Insulin Sensitivity
J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 4615 - 4617.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Katz, S. S. Nambi, K. Mather, A. D. Baron, D. A. Follmann, G. Sullivan, and M. J. Quon
Quantitative Insulin Sensitivity Check Index: A Simple, Accurate Method for Assessing Insulin Sensitivity In Humans
J. Clin. Endocrinol. Metab., July 1, 2000; 85(7): 2402 - 2410.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Colao, R. Pivonello, S. Spiezia, A. Faggiano, D. Ferone, M. Filippella, P. Marzullo, G. Cerbone, M. Siciliani, and G. Lombardi
Persistence of Increased Cardiovascular Risk in Patients with Cushing's Disease after Five Years of Successful Cure
J. Clin. Endocrinol. Metab., August 1, 1999; 84(8): 2664 - 2672.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
N. B. Ruderman, A. K. Saha, D. Vavvas, and L. A. Witters
Malonyl-CoA, fuel sensing, and insulin resistance
Am J Physiol Endocrinol Metab, January 1, 1999; 276(1): E1 - E18.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
M. W. Schwartz and R. J. Seeley
Neuroendocrine Responses to Starvation and Weight Loss
N. Engl. J. Med., June 19, 1997; 336(25): 1802 - 1811.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1996 by the American Diabetes Association.